Evaluation of the ResistancePlus MG FleXible Cartridge for Near-Point-of-Care Testing of Mycoplasma genitalium and Associated Macrolide Resistance Mutations

J Clin Microbiol. 2020 Feb 24;58(3):e01897-19. doi: 10.1128/JCM.01897-19. Print 2020 Feb 24.

E L Sweeney¹, L P Mhango², S Ebeyan³, L Y Tan³, C Bletchly⁴, G R Nimmo^{4

5}, D M Whiley^{1

4}

¹ University of Queensland Centre for Clinical Research (UQ-CCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia e.l.sweeney@uq.edu.au d.whiley@uq.edu.au.
² University of Queensland Centre for Clinical Research (UQ-CCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
³ SpeeDx Pty Ltd., Sydney, New South Wales, Australia.
⁴ Pathology Queensland Central Laboratory, Queensland, Australia.
⁵ Griffith University, School of Medicine, Queensland, Australia.

No abstract available

Keywords: Mycoplasma genitalium; SpeeDx; antimicrobial resistance; azithromycin; macrolide; near point-of-care.

Publication types